| Literature DB >> 35845597 |
Senwei Zhang1, Ping Ma2, Qiu Chen3.
Abstract
Objective: We aimed to analyze the correlation between the level of skin advanced glycation end products (AGEs) in type 2 diabetes mellitus (T2DM) patients and the diabetic retinopathy (DR) staging in different traditional Chinese medicine (TCM) syndromes.Entities:
Year: 2022 PMID: 35845597 PMCID: PMC9286975 DOI: 10.1155/2022/5193944
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Comparison of primary data of different DR staging groups.
| Normal group ( | Mild NPDR group ( | Middle NPDR group ( | Severe NPDR group ( | PDR group ( | |
|---|---|---|---|---|---|
| Gender (male/female) | 119/67 | 63/51 | 39/29 | 17/10 | 14/7 |
| Age (years) [M (Q)] | 56.8 (7.4) | 59.8 (7.7) | 57.5 (9.4) | 65.5 (5.1) | 62.8 (6.0) |
| Height (cm) | 163.3 ± 5.7 | 161.8 ± 6.9 | 163.0 ± 7.5 | 162.3 ± 7.1 | 155.3 ± 6.8 |
| Weight (kg) | 66.1 ± 4.8 | 68.9 ± 5.0 | 66.4 ± 6.4 | 64.0 ± 6.4 | 58.0 ± 7.5 |
| Course of disease (year) | 3.0 ± 1.6 | 3.5 ± 1.8 | 3.4 ± 1.1 | 3.5 ± 1.5 | 3.3 ± 1.7 |
| FPG (mmol/L) | 9.4 ± 1.4 | 9.7 ± 1.9 | 10.2 ± 1.6 | 11.7 ± 2.8 | 10.5 ± 2.1 |
| HbA1c (%) | 8.7 ± 1.7 | 8.5 ± 1.6 | 9.2 ± 2.0 | 8.7 ± 2.1 | 9.2 ± 1.7 |
| TC (mmol/L) | 4.4 ± 1.7 | 4.7 ± 1.6 | 4.5 ± 1.3 | 5.5 ± 1.4 | 5.1 ± 2.7 |
| TG (mmol/L) | 1.3 ± 0.7 | 1.5 ± 0.7 | 1.7 ± 0.8 | 2.0 ± 0.4 | 1.3 ± 0.5 |
| LDL (mmol/L) | 2.1 ± 0.8 | 2.7 ± 0.9 | 2.7 ± 0.5 | 2.5 ± 0.8 | 2.2 ± 1.1 |
| HDL (mmol/L) | 1.5 ± 0.8 | 1.1 ± 0.5 | 1.4 ± 0.9 | 1.3 ± 0.5 | 1.4 ± 0.4 |
| UMA (g/L) | 42.6 ± 7.5 | 70.8 ± 9.5 | 126.6 ± 23.2 | 315.7 ± 37.5 | 298.6 ± 64.8 |
Figure 1Skin AGEs levels in different DR stages.
Comparison of skin AGEs levels in different DR staging groups.
| Group | AGEs |
|---|---|
| Normal group ( | 90.1 ± 13.8 |
| Mild NPDR group ( | 93.0 ± 17.3 |
| Middle NPDR group ( | 93.5 ± 15.5 |
| Severe NPDR group ( | 104.8 ± 14.8 |
| PDR group ( | 104.0 ± 9.5 |
|
| 21.046 |
|
| <0.001 |
Correlation analysis between skin AGEs levels and various indicators.
| Index | Correlation analysis | Correlation coefficient |
|
|---|---|---|---|
| HbA1c | Pearson | 0.511 | <0.01 |
| TC | Pearson | 0.463 | <0.01 |
| LDL | Pearson | 0.502 | <0.01 |
| UMA | Pearson | 0.411 | <0.01 |
| DR staging | Spearman | 0.467 | <0.01 |
Comparison of basic data of different TCM syndrome groups.
| Qi and yin deficiency, collateral and vessel stasis syndrome group ( | Liver and kidney deficiency, eye and collateral dystrophy syndrome group ( | Yin and yang deficiency, blood stasis and phlegm coagulation group ( | |
|---|---|---|---|
| Gender (male/female) | 39/33 | 60/39 | 34/25 |
| Age (year) [M (Q)] | 59.5 (8.1) | 57.4 (9.2) | 59.5 (8.8) |
| Height (cm) | 162.9 ± 4.9 | 160.6 ± 8.3 | 162.6 ± 6.8 |
| Wight (kg) | 64.7 ± 6.0 | 67.6 ± 7.3 | 66.9 ± 7.5 |
| The course of disease (year) | 3.3 ± 1.7 | 3.4 ± 1.5 | 3.6 ± 1.6 |
| FPG (mmol/L) | 9.6 ± 1.8 | 9.6 ± 1.3 | 9.5 ± 1.7 |
| HbA1c (%) | 8.6 ± 1.9 | 9.0 ± 1.4 | 8.9 ± 1.5 |
| TC (mmol/L) | 4.6 ± 1.5 | 4.5 ± 1.8 | 4.5 ± 1.8 |
| TG (mmol/L) | 1.6 ± 0.5 | 1.6 ± 0.7 | 1.5 ± 0.6 |
| LDL (mmol/L) | 2.4 ± 0.8 | 2.8 ± 0.6 | 2.5 ± 0.9 |
| HDL (mmol/L) | 1.3 ± 0.9 | 1.2 ± 0.4 | 1.1 ± 0.5 |
| UMA (g/L) | 85.9 ± 13.2 | 79.4 ± 18.4 | 95.36 ± 33.8 |
Figure 2Skin AGEs levels in different TCM syndrome groups.
Comparison of skin AGEs levels in different TCM syndrome groups.
| Group | AGEs |
|---|---|
| Deficiency of qi and yin deficiency, collateral and vessel stasis syndrome ( | 93.5 ± 3.6 |
| Deficiency of liver and kidney deficiency, dystrophy of eye and collaterals ( | 90.1 ± 4.2 |
| Yin and yang deficiency, blood stasis and phlegm coagulation syndrome ( | 97.7 ± 3.1 |
|
| 23.267 |
|
| <0.001 |